- Browse/Search the Program
Search
Browse By Day
Browse By Time
Browse By Person
Browse By Mini-Conference
Browse By Division
Browse By Session or Event Type
Browse Sessions by Fields of Interest
Browse Papers by Fields of Interest
- Information Menu
Search Tips
Conference
Location
About APSA
- Navigation and Settings Menu
Personal Schedule
Change Preferences / Time Zone
Sign In
- Social Media Menu
Facebook
X (Twitter)
Medicaid and Drug Policy
Fri, September 6, 10:00 to 11:30am, Loews Philadelphia Hotel, Commonwealth A1Session Submission Type: Created Panel
Session Description
This panel looks at Medicaid and various drug-related policies. Topics include: Medicaid and healthcare access for low-income families, Medicaid and cost-containment, the use of evidence with the opioid crisis, the policy consequences of Ozempic, and the association between the build environment and medical marijuana.
Sub Unit
Individual Presentations
Contracted Out Medicaid and Healthcare Access for Low-income Families: Connecticut’s Managed Care Withdrawal - Soyun Jeong, University at Albany - SUNY
COVID-19 and State Medicaid Cost-Containment Strategies - Shihyun Noh, SUNY Brockport
The Scientific Foundation of the Opioid Crisis: The Misuse of Evidence - Ravi Gupta, Johns Hopkins University
The Policy Consequences of Support for Regulating Off-Label Ozempic Prescription - Timothy Herbert Callaghan, Boston University; Matt Motta, Boston University School of Public Health; Robert Kirby Goidel, Texas A&M
Medical Marijuana's Built Environment: Dispensary Locations and Patient Access - Lee Hannah, Wright State University; Cogan Shimizu, Wright State University; Rakesh Kandula, Wright State University; Daniel J Mallinson, Penn State, Harrisburg